Summary
Apex Technology Acquisition Corporation reported net income of $815,685 for the quarter ended March 31, 2020, and diluted earnings per share of $0.03. The same quarter produced an operating loss of $0.24 million and operating cash flow of negative $0.38 million. Those four figures are the whole of the GAAP picture, because this is a blank check company with no commercial operations.
The profit came entirely from the trust account. Interest income on marketable securities held in the trust account reached $1,452,414 for the three months ended March 31, 2020. Operating costs of $194,283, franchise taxes of $50,000 and a provision for income taxes of $392,446 absorbed part of that interest. Apex has generated no revenue to date and does not expect any operating revenue until after it closes an initial business combination. Its only activities since inception have been organizational work, preparation for the initial public offering and the search for a target.
Cash used in operating activities was $382,908 for the three months ended March 31, 2020. Net income of $815,685 was offset by $1,452,414 of interest earned on marketable securities held in the trust account, while changes in operating assets and liabilities provided $253,821 of cash. As of March 31, 2020, the company held investments of $353,112,834 in the trust account and cash of $760,645 outside it. It withdrew $148,743 of trust account interest during the quarter to cover franchise tax obligations.
The September 19, 2019 initial public offering raised gross proceeds of $350,000,000 from 35,000,000 units priced at $10.00 each. The concurrent sale of 810,000 placement units to the sponsor and Cantor brought in another $8,100,000. Transaction costs totaled $19,806,442, made up of $6,100,000 of underwriting fees, $13,150,000 of deferred underwriting fees and $556,442 of other offering costs. All $350,000,000 of the offering proceeds went into the trust account.
The central risk is that no business combination has been signed. The underwriters hold a claim to a deferred fee of $13,150,000 that becomes payable from trust assets only if a deal closes. An affiliate of the sponsor collects $15,000 a month for office space, utilities and administrative support. The sponsor or its affiliates may advance up to $1,500,000, and those loans can convert into units at $10.00 each at the lender's option. Management says it does not expect to need additional funds to run the business, but it warns that if due diligence and negotiation cost more than estimated, the company could run short of money before a deal closes. In that event it would have to cease operations and liquidate the trust account.
Other risks sit in the structure itself. Issuing shares to target owners would dilute public investors, and the anti-dilution terms of the Class B stock could make that dilution worse. Preferred stock with senior rights could subordinate common holders. A large share issuance could trigger a change of control and limit the use of net operating loss carryforwards. Debt raised for a deal could lead to default, foreclosure on assets, or acceleration of repayment if covenants are breached. The filing gives no revenue or earnings outlook for the second quarter or the full fiscal year, which is unsurprising for a shell company that has yet to name a target.
Forecast
No forward guidance in this quarter's filings.
Reported figures
GAAP, from SEC filings| Metric | Q1 FY2020 | Q4 FY2019 | QoQ | Q1 FY2019 | YoY |
|---|---|---|---|---|---|
| Sales & marketing | $194.3K | — | — | — | — |
| General & administrative | $15.0K | — | — | — | — |
| Operating income (loss) | -$244.3K | — | — | — | — |
| Net income (loss) | $815.7K | — | — | — | — |
Risks
The filing states that the search for a business combination and any target business may be materially adversely affected by the COVID-19 outbreak, which was declared a pandemic on March 11, 2020. Travel restrictions and the unavailability of target personnel, vendors and service providers could prevent the company from negotiating and consummating a transaction in a timely manner.
The company has neither engaged in operations nor generated any revenues to date, and does not expect operating revenues until after a business combination. If it cannot complete a combination because it lacks sufficient funds, the filing states it will be forced to cease operations and liquidate the trust account.
The MD&A warns that if the estimated costs of identifying a target, performing due diligence and negotiating a combination are less than the actual amount necessary, the company may have insufficient funds to operate prior to the combination and may need to raise additional financing or incur debt.
The filing states that issuing additional shares in connection with a business combination may significantly dilute the equity interest of IPO investors, with dilution increasing if anti-dilution provisions in the Class B common stock result in Class A shares issued on a greater than one-to-one basis.
The MD&A details that incurring significant debt to complete a combination could result in default and foreclosure on assets, acceleration of repayment obligations upon covenant breach, and reduced flexibility to react to changes in the business and industry.
Summary, forecast, risks and KPIs are extracted from AvePoint, Inc.'s SEC filings for Q1 FY2020 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 21, 2026.